Free Trial
NASDAQ:NMRD

Nemaura Medical (NMRD) Stock Price, News & Analysis

Nemaura Medical logo

About Nemaura Medical Stock (NASDAQ:NMRD)

Key Stats

Today's Range
N/A
50-Day Range
$0.00
$0.03
52-Week Range
N/A
Volume
N/A
Average Volume
6,262 shs
Market Capitalization
$10,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.

Receive NMRD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nemaura Medical and its competitors with MarketBeat's FREE daily newsletter.

NMRD Stock News Headlines

Nemaura Medical Inc (NMRD)
JD Vance Predicts: Wall Street vs. Trump & Your Money
Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.
NXNN Nexeon Medsystems Inc
See More Headlines

NMRD Stock Analysis - Frequently Asked Questions

Nemaura Medical Inc. (NASDAQ:NMRD) posted its quarterly earnings data on Monday, February, 12th. The company reported ($0.12) earnings per share (EPS) for the quarter.

Shares of NMRD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nemaura Medical investors own include Ford Motor (F), Pfizer (PFE), Palantir Technologies (PLTR), Meta Platforms (META), Exxon Mobil (XOM), Agile Therapeutics (AGRX) and Tesla (TSLA).

Company Calendar

Last Earnings
2/12/2024
Today
11/21/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:NMRD
Fax
N/A
Employees
40
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$80,000.00
Book Value
($0.41) per share

Miscellaneous

Free Float
24,042,000
Market Cap
$10,000.00
Optionable
No Data
Beta
0.09
Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report

This page (NASDAQ:NMRD) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners